Health Policy
News from the FDA/CDC
FDA expands use of dapagliflozin to broader range of HF
The sodium-glucose cotransporter 2 inhibitor was previously approved in the United States for adults with heart failure with reduced ejection...
News from the FDA/CDC
Single bivalent COVID booster is enough for now: CDC
Booster strength wanes after a few months, spurring discussions of whether people at high risk of getting a severe case of COVID may need more...
News
Frustration over iPLEDGE evident at FDA meeting
Dermatologists argue the iPLEDGE REMS burden is too high for providers and patients. Access problems persist with lockouts and some cite a lack of...
News
EPA seeks to limit ‘forever’ chemicals in U.S. drinking water
The Environmental Protection Agency is proposing a new rule that would greatly limit the concentration of endocrine-disrupting ‘forever’ chemicals...
News from the FDA/CDC
New challenge for docs: End of COVID federal public health emergency
The Biden administration intends to end by May 11 certain COVID-19 emergency measures used to aid in the response to the pandemic.
Commentary
The five biggest changes in the 2023 adult vaccine schedules
COVID vaccines are now front and center among 2023’s five most important changes.
News
Biden to end COVID emergencies in May
Doing so will have many effects, including the end of free vaccines and health services to fight the pandemic.
News
FDA wants annual COVID boosters, just like annual flu shots
The booster’s formulation would be selected in June targeting the most threatening COVID-19 strains.
Opinion
The marked contrast in pandemic outcomes between Japan and the United States
Over time Japan has the least cumulative deaths per capita of any major country in the world.
News
Experts: EPA should assess risk of sunscreens’ UV filters
The assessment is urgently needed and the results should be shared with the Food and Drug Administration, the experts said.